Are we overmedicating our kids for sleep issues? A startling new review published in JAMA Network raises serious concerns about the skyrocketing use of melatonin in children, especially those with typical development. But here's where it gets controversial: while melatonin is often seen as a harmless sleep aid, the study reveals a shocking lack of evidence supporting its long-term use or effectiveness in kids without conditions like autism spectrum disorder (ASD).
The systematic review analyzed 19 studies and found that melatonin prescriptions have surged dramatically, with some reporting a staggering 500% increase. Even more alarming, extended use and overdoses in children up to six years old have risen sharply over the past two decades. And this is the part most people miss: only five international trials showed that melatonin helps children with ASD fall asleep faster, but none examined its efficacy in neurotypical children or tracked outcomes beyond two years.
This raises a critical question: Why are we prescribing melatonin so freely when the data is so limited? The study authors argue that behavioral strategies, such as reducing screen time before bed and establishing consistent bedtime routines, should be the first line of defense. These approaches not only address sleep issues without medication but also empower parents with practical tools.
Dr. Tim Jones, Chair of the RACGP Specific Interests Child and Young Person’s Health, emphasizes the distinction between short-term melatonin use as part of a broader sleep support plan and its uncertain long-term benefits. He recommends that GPs prioritize behavioral interventions, leveraging resources like Sleep with Kip or partnering with organizations like Karitane, which specialize in childhood sleep health.
If melatonin is prescribed, it should be for short-term use (less than six weeks) alongside other strategies, with close follow-up to gradually wean children off the medication. Here’s a bold statement: We have no evidence of melatonin’s efficacy or safety beyond 12 weeks, yet it’s becoming a go-to solution for sleep troubles. Is this a case of convenience overshadowing caution?
In the U.S., melatonin leads in cases of unsupervised ingestion and overdose among children under five, with incidents increasing fivefold from 2009 to 2021. Australia’s Therapeutic Goods Administration has also flagged concerns, finding that many imported melatonin products contain significantly more or less of the active ingredient than labeled. One product even contained over 400% of the claimed amount—a terrifying prospect for parents.
A recent ABC investigation uncovered 1,478 calls to the poisons hotline in 2024 related to melatonin exposure in children 14 and younger. This highlights not only the risks of misuse but also the need for better regulation and education.
So, what’s the takeaway? Sleep challenges are a universal part of parenting, but medicalizing them without robust evidence could do more harm than good. As Dr. Jones puts it, GPs play a vital role in destigmatizing sleep issues and offering families respectful, practical support. Normalizing these struggles and exploring non-pharmacological solutions should be our priority.
Controversial question for you: Is melatonin being overprescribed, or are we simply lacking the tools to address childhood sleep issues effectively? Share your thoughts in the comments—let’s spark a conversation that could shape how we approach this growing concern.
